We are live on
!
Find out more
PVWM
Point View Wealth Management Portfolio holdings
AUM
$246M
1-Year Est. Return
10.77%
This Fund
S&P 500
This Quarter
Est. Return
+2.94%
1 Year Est. Return
+10.77%
3 Year Est. Return
+27.03%
5 Year Est. Return
+74.48%
10 Year Est. Return
–
AUM
$235M
AUM Growth
+$10M
(+4.5%)
Cap. Flow
+$5.19M
Cap. Flow
% of AUM
2.21%
Top 10 Holdings %
Top 10 Hldgs %
15.52%
Holding
284
New
13
Increased
69
Reduced
134
Closed
10
Avg Time Held
14.1
quarters
Top 10 Avg Time Held
10.5
quarters
Top 20 Avg Time Held
11.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$759K |
| 2 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$618K |
| 3 |
Mexico Fund
MXF
|
+$603K |
| 4 |
Du Pont De Nemours E I
DD
|
+$508K |
| 5 |
Walgreens Boots Alliance
WBA
|
+$455K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GG
Goldcorp Inc
GG
|
+$313K |
| 2 |
NOV
NOV
|
+$214K |
| 3 |
Honda
HMC
|
+$203K |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$203K |
| 5 |
Cummins
CMI
|
+$201K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 13.73% |
| 2 | Technology | 12.84% |
| 3 | Healthcare | 11.46% |
| 4 | Financials | 10.84% |
| 5 | Industrials | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Archer Daniels Midland
ADM
$38.8B
| $996K | 0.42% |
24,420
-35
| -0.1% | -$1.45K |
2013 Q4
22 quarters
|
|
77
Gilead Sciences
GILD
$186B
| $974K | 0.41% |
14,424
+49
| +0.3% | +$3.22K |
2016 Q1
13 quarters
|
|
78
Valero Energy
VLO
$124B
| $973K | 0.41% |
11,370
| – | – |
2013 Q4
22 quarters
|
|
79
Unilever
UL
$135B
| $944K | 0.4% |
13,538
-337
| -2% | -$22.9K |
2015 Q1
17 quarters
|
|
80
Brighthouse Financial
BHF
$2.81B
| $929K | 0.4% |
25,315
+1,116
| +5% | +$43.1K |
2018 Q2
4 quarters
|
|
81
John Hancock Financial Opportunities Fund
BTO
$727M
| $919K | 0.39% |
28,537
| – | – |
2013 Q4
22 quarters
|
|
82
Bank of New York Mellon
BNY
$97.2B
| $915K | 0.39% |
20,714
-130
| -0.6% | -$6.11K |
2013 Q4
22 quarters
|
|
83
CSX Corp
CSX
$88B
| $913K | 0.39% |
35,400
-57
| -0.2% | -$1.47K |
2013 Q4
22 quarters
|
|
84
Mondelez International
MDLZ
$78.2B
| $913K | 0.39% |
16,938
+127
| +0.8% | +$6.59K |
2015 Q2
16 quarters
|
|
85
Altria Group
MO
$119B
| $886K | 0.38% |
18,707
+949
| +5% | +$49.7K |
2013 Q4
22 quarters
|
|
|
BF
86
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
| $875K | 0.37% |
48,100
+988
| +2% | +$18K |
2018 Q4
2 quarters
|
|
87
Diageo
DEO
$48.9B
| $866K | 0.37% |
5,025
-71
| -1% | -$11.9K |
2015 Q3
15 quarters
|
|
88
Cigna
CI
$74.7B
| $849K | 0.36% |
5,389
+53
| +1% | +$8.31K |
2013 Q4
22 quarters
|
|
|
AGN
89
DELISTED
Allergan plc
AGN
| $840K | 0.36% |
5,017
-557
| -10% | -$77.1K |
2015 Q4
14 quarters
|
|
90
AstraZeneca
AZN
$246B
| $827K | 0.35% |
10,021
+55
| +0.6% | +$4.31K |
2013 Q4
22 quarters
|
|
91
Apple
AAPL
$4.98T
| $825K | 0.35% |
16,680
-28
| -0.2% | -$1.36K |
2016 Q4
10 quarters
|
|
92
Devon Energy
DVN
$53.7B
| $825K | 0.35% |
28,929
+352
| +1% | +$10.5K |
2016 Q2
12 quarters
|
|
93
Central and Eastern Europe Fund
CEE
$122M
| $821K | 0.35% |
30,177
| – | – |
2015 Q2
16 quarters
|
|
94
Baker Hughes
BKR
$56.2B
| $804K | 0.34% |
32,630
-436
| -1% | -$10.5K |
2017 Q3
7 quarters
|
|
95
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
| $796K | 0.34% |
56,419
| – | – |
2013 Q4
22 quarters
|
|
96
Novartis
NVS
$272B
| $782K | 0.33% |
8,559
-1,021
| -11% | -$86.4K |
2013 Q4
22 quarters
|
|
97
General Dynamics
GD
$90.7B
| $778K | 0.33% |
4,280
-169
| -4% | -$29.1K |
2013 Q4
22 quarters
|
|
98
Kirby Corp
KEX
$7.17B
| $773K | 0.33% |
9,779
-48
| -0.5% | -$3.85K |
2016 Q1
13 quarters
|
|
99
Baxter International
BAX
$12.7B
| $767K | 0.33% |
9,364
-384
| -4% | -$29.8K |
2015 Q4
14 quarters
|
|
100
Prudential Financial
PRU
$39.2B
| $761K | 0.32% |
7,533
-338
| -4% | -$33.7K |
2013 Q4
22 quarters
|
|
Similar funds
EA
CCM
JCM
BG
MCFIG
BRC
TFM
RCA
Point View Wealth Management's Q2 2019 Portfolio in Review
As of Q2 2019, Point View Wealth Management held 284 positions worth $235M, up 4.5% from $225M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Point View Wealth Management's Q2 2019 filing shows 13 new, 69 increased, 134 reduced and 10 closed positions. Its largest new stake was Mexico Fund: 43,015 shares worth $591K. The largest sale was Goldcorp Inc, an estimated $313K.
By sector, the portfolio is most concentrated in Miscellaneous at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- Point View Wealth Management's largest Q2 2019 buy was Mexico Fund: 43,015 shares worth $591K.
- Point View Wealth Management added most to CVS Health in Q2 2019, an estimated $759K increase.
- Point View Wealth Management's biggest Q2 2019 reduction was E*Trade Financial Corporation, cutting an estimated $143K.
- Point View Wealth Management fully exited Goldcorp Inc in Q2 2019, selling an estimated $313K.
- Point View Wealth Management's ten largest holdings make up 16% of its $235M portfolio in Q2 2019.
- Point View Wealth Management opened 13 new positions and closed 10 in Q2 2019.
- Point View Wealth Management's portfolio value rose 4.5% quarter-over-quarter to $235M.
Based on Point View Wealth Management's 13F filing for Q2 2019, filed 29 Jul 2019.